Latest debt-to-equity ratio
Royalty Pharma Debt-to-equity ratio
Direct answer
Royalty Pharma's debt-to-equity ratio is 91.58%.
The verified market snapshot reports 91.58%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 30, 2026.
Get free Royalty Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 91.58%
Explore related company data
View Royalty Pharma's market capitalizationView Royalty Pharma's p/e ratioView Royalty Pharma's price-to-book ratioView Royalty Pharma's return on equityView Royalty Pharma's dividend yieldView Royalty Pharma's 52-week price rangeView Royalty Pharma's revenue growthView Royalty Pharma's profit marginView all Royalty Pharma key metricsReturn to Royalty Pharma profile